Figure 3From: Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathiesTUNEL assay in sections from (A) Wilms tumor and muscle from (B) P7, (C,D) (P7) patients 3 and 4 with mutations in TK2 . Scale bar = 25 μm.Back to article page